project id: TCGA-BRCA; case submitter id: TCGA-AO-A03O; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 69; days to birth: -25362; days to death: 2483; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1933; year of death: 2008; age at diagnosis: 25362; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2002; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2694; days to sample procurement: 0; initial weight: 690.0; portion submitter id: TCGA-AO-A03O-01A-11; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0;